VERU INC.
For the period ended Dec 17, 2025. Filed Dec 17, 2025.
View on SEC.govAbout this filing
A notice of a major event between regular reports, such as results, a deal or a change of executives. It is often the first formal record of the news.
Dec 17, 2025 · Filed Dec 17, 2025
Use the contents to explore the available documents and sections.
VERU$2.12+2.9%Stored close · as of Nov 6, 2026
Contents
EX-99.1 · FDA Regulatory Feedback
FDA Regulatory Feedback
In September 2025, the Company announced a successful FDA meeting providing regulatory clarity for enobosarm in combination with GLP-1 RA for greater weight loss in the treatment of obesity
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.